More than ever before, Democratic presidential hopefuls want to take on pharma. Here’s how they’d do so
The post below is adapted from a STAT Report, “Democrats and drug pricing,” a deeply reported examination of how the 2020 presidential candidates could reshape the pharmaceutical industry. You can access the full version here.
President Trump has made drug pricing a key policy tenet of his three-year tenure in the White House. And as his drug pricing policy has grown more aggressive in the past year, his Democratic challengers in the 2020 election have responded in kind.
